Infectious Disease Diagnostics Market Report: Trends, Forecast and Competitive Analysis to 2030

Infectious Disease Diagnostics Market Report: Trends, Forecast and Competitive Analysis to 2030

Infectious Disease Diagnostics Trends and Forecast

The future of the global infectious disease diagnostics market looks promising with opportunities in the immunodiagnostics, NGS, INAAT, and PCR markets. The global infectious disease diagnostics market is expected to reach an estimated $49.9 billion by 2030 with a CAGR of 5.1% from 2024 to 2030. The major drivers for this market are increasing prevalence of infectious diseases and the rising awareness about early disease detection.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Infectious Disease Diagnostics by Segment

The study includes a forecast for the global infectious disease diagnostics by product, test type, technology, end use, and region.

Infectious Disease Diagnostics Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Reagents, Kits, and Consumables
• Instruments
• Software & Services

Infectious Disease Diagnostics Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

• Lab
• POC

Infectious Disease Diagnostics Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Immunodiagnostics
• NGS
• INAAT
• PCR

Infectious Disease Diagnostics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Labs

Infectious Disease Diagnostics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Infectious Disease Diagnostics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies infectious disease diagnostics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the infectious disease diagnostics companies profiled in this report include-

• Abbott Laboratories
• Thermo Fisher Scientific
• F. Hoffmann-La Roche
• bioMérieux
• Siemens Healthineers
• Danaher Corporation
• Becton and Dickinson

Infectious Disease Diagnostics Market Insights

Lucintel forecasts that reagents, kits, and consumables will remain the largest segment over the forecast period due to recurrent usage of these products.

Within this market, immunodiagnostics will remain the largest segment due to increasing usage of immunoassays in covid-19 testing, POC infectious disease testing, and others.

North America will remain the largest region over the forecast period due to high incidence of infections, established healthcare infrastructure, and rising healthcare expenditure in the region.

Features of the Global Infectious Disease Diagnostics Market

Market Size Estimates: Infectious disease diagnostics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Infectious disease diagnostics market size by various segments, such as by product, test type, technology, end use, and region in terms of value ($B).

Regional Analysis: Infectious disease diagnostics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, test types, technologies, end uses, and regions for the infectious disease diagnostics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the infectious disease diagnostics market.

Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the infectious disease diagnostics market size?

Answer: The global infectious disease diagnostics market is expected to reach an estimated $49.9 billion by 2030.

Q2. What is the growth forecast for infectious disease diagnostics market?

Answer: The global infectious disease diagnostics market is expected to grow with a CAGR of 5.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the infectious disease diagnostics market?

Answer: The major drivers for this market are increasing prevalence of infectious diseases and the rising awareness about early disease detection.

Q4. What are the major segments for infectious disease diagnostics market?

Answer: The future of the infectious disease diagnostics market looks promising with opportunities in the immunodiagnostics, NGS, INAAT, and PCR markets.

Q5. Who are the key infectious disease diagnostics market companies?

Answer: Some of the key infectious disease diagnostics companies are as follows:

• Abbott Laboratories
• Thermo Fisher Scientific
• F. Hoffmann-La Roche
• bioMérieux
• Siemens Healthineers
• Danaher Corporation
• Becton and Dickinson

Q6. Which infectious disease diagnostics market segment will be the largest in future?

Answer: Lucintel forecasts that reagents, kits, and consumables will remain the largest segment over the forecast period due to recurrent usage of these products.

Q7. In infectious disease diagnostics market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to high incidence of infections, established healthcare infrastructure, and rising healthcare expenditure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the infectious disease diagnostics market by product (reagents, kits, and consumables, instruments, and software & services), test type (lab and POC), technology (immunodiagnostics, NGS, INAAT, and PCR), end use (hospitals and labs), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Please note: It will take 3 business days to deliver the report upon receipt the order.